Using e-Technologies to Maximize Physical Activity After Cancer Treatment

NCT07535918 | Not Yet Recruiting

• 1 other identifier: IRB202501619
• Study Type: interventional
• Target: 750
• Locations: 0 countries
• Sites: N/A

Brief Summary

The Cancer Exercise app (CEA) is designed to promote physical activity among cancer survivors. The proposed randomized controlled clinical trial will investigate, in adults who have completed cancer treatment, the effects of a 12-week home-based exercise program, delivered using CEA, on physical activity levels. Participants will be randomized into one of two groups: (1) CEA or (2) Usual Care.

Conditions

Cancer

Outcome Measures

Primary Outcomes (1)

• Change in moderate to vigorous physical activity from pre- to post-intervention

  Moderate to vigorous physical activity will be assessed using the International Physical Activity Questionnaire, a well-validated and reproducible questionnaire for use among cancer survivors

  Baseline and following the 12-week intervention

Study Arms (2)

Cancer Exercise app group

EXPERIMENTAL

Behavioral: Cancer Exercise App

Usual Care group

NO INTERVENTION

Participants assigned to Usual Care group will receive no intervention. After completing the post-intervention assessments, they will be provided with information on how to download and use the Cancer exercise app.

Interventions

Cancer Exercise App BEHAVIORAL

Use of Cancer Exercise app to increase physical activity levels among cancer survivors.

Cancer Exercise app group

Eligibility Criteria

• Age: 18 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• to 85 years of age
• Diagnosed with stage I-III cancer
• Completed all primary cancer treatments (e.g., surgery, radiation, chemotherapy) at least 6 months prior to enrollment. Adjuvant endocrine therapy, CDK4/6 inhibitors, PARP inhibitors, immunotherapy, and bisphosphonates are allowed within 6 months of study enrolment and during study participation.
• Own a smartphone with data plan or access to WiFi (Apple or Android)
• Medical clearance provided or no medical clearance needed based on exercise preparticipation screening.

You may not qualify if:

• consistently engage in \>300 min/week of moderate-intensity physical activity or 150 min/week of vigorous-intensity physical activity in the past 3 months
• receiving or scheduled to receive surgery or radiation during study participation
• have stage IV metastatic cancer or evidence of cancer recurrence
• have multiple myeloma
• have received bone marrow or hematopoietic stem cell transplant within past year
• are unable to walk without support or have severe weakness or balance problems that limit safe participation in exercise
• contraindications to participate in unsupervised exercise
• are pregnant
• unable to read, speak and understand English

Sponsors & Collaborators

• University of Florida: lead
• University of Florida Health Cancer Institute: collaborator

MeSH Terms

Conditions

Neoplasms

Study Officials

• Demetra Christou, PhD

  University of Florida

  PRINCIPAL INVESTIGATOR

• Danielle Jake-Schoffman, PhD

  University of Florida

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Research Coordinator

CONTACT

(352) 294-1742; eMPACT@hhp.ufl.edu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 10, 2026
• First Posted: April 17, 2026
• Study Start: May 1, 2026
• Primary Completion (Estimated): May 1, 2028
• Study Completion (Estimated): May 1, 2028
• Last Updated: April 22, 2026

Record last verified: 2026-04

Data Sharing

• IPD Sharing: Will not share